Listen Live

Current Weather

Loading advertisement…

Sanofi to acquire US biotech Dynavax for $2.2 billion

(Corrects acquisition completion year to 2026 in paragraph 3) Dec 24 (Reuters) - French drugmaker Sanofi has entered into an agreement to acquire U.S. vaccines company Dynavax Technologies Corporation for around $2.2 billion (1.87 billion euros), it said on Wednesday. Under the terms disclosed, Sanofi will... Read More.